FDA Recalls 4.3 Million Tubes of Toothpaste Nationwide

More than 4.3 million tubes of adult and children's toothpaste have been recalled across the United States after the Food and Drug Administration identified deviations from manufacturing standards. The voluntary recalls, initiated by India's Pritam International Private Limited on September 10, 2026, cover 17 product varieties distributed by Ashtel Studios Inc. of Ontario, California, according to federal records published in October.

Federal reports cited current good manufacturing practice (cGMP) deviations as the reason for the recalls but did not specify the exact manufacturing problems. The FDA classified the products as Class II, a category covering products that may cause temporary or medically reversible health consequences, with the likelihood of serious harm considered remote.

According to an October 20 report by WGAL, the 17 recalls cover a combined 4,301,700 tubes. An October 19 FDA enforcement report cited by NTD listed 4,298,900 tubes, leaving a difference of 2,800 between the reported totals.

The affected products include children's toothpaste featuring Barbie, Hot Wheels, Crayola and My Little Pony characters, along with several ice cream-flavored varieties. The recalls also cover whitening, sensitivity, gum-health and cavity-protection toothpastes sold under the Brush Buddies, evo and ARU brands.

Expiration dates for the recalled products range from November 2026 through June 2028, according to WGAL. The products were distributed nationwide and sold online through eBay and Amazon, according to NTD.

Darin Detwiler, a Northeastern University professor, food safety expert and adviser to the Alliance for Recall Ready Communities, said manufacturing deviations can undermine product safety and quality controls.

"Deviations from cGMPs can compromise the integrity of the entire production process," Detwiler told NTD.

Current good manufacturing practice regulations establish requirements for controlled production, including quality management systems, appropriate raw materials, documented operating procedures, investigations into quality deviations and reliable testing laboratories. These safeguards are intended to help manufacturers maintain product quality, cleanliness, consistency and safety.

Detwiler said a recall involving millions of units indicates that regulators and the manufacturer identified a potential risk significant enough to warrant removing the products from the market.

"While a violation might not always result in immediate health threats, when a recall of this size happens, it means the FDA and the company found enough of a potential risk—such as contamination or quality failure—that it wasn’t worth gambling with public safety," he added.

The FDA's Class II designation indicates that exposure to the affected products could result in temporary or medically reversible health effects. Federal officials have not publicly specified the precise manufacturing deviations behind the recalls, and WGAL reported that its request for additional comment from the FDA had not received a response.